“ Emma Beavins reports that gridlock in the Biden administration on allowing schedule II substances, like Adderall for ADHD, to be prescribed via telehealth could roll back progress on virtual prescribing. Stakeholders fear time is running out to extend pandemic-era telehealth flexibilities before they expire.”